Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-14-003877
Filing Date
2014-06-02
Accepted
2014-05-30 19:50:38
Documents
12
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2013_calderapharma.htm 10-K 2007329
2 EMPLOYMENT AGREEMENT f10k2013ex10xiii_caldera.htm EX-10.13 49018
3 CERTIFICATION f10k2013ex31i_caldera.htm EX-31.1 16977
4 CERTIFICATION f10k2013ex31ii_caldera.htm EX-31.2 16683
5 CERTIFICATION f10k2013ex32i_caldera.htm EX-32.1 6511
6 CERTIFICATION f10k2013ex32ii_caldera.htm EX-32.2 6482
  Complete submission text file 0001213900-14-003877.txt   10455830

Data Files

Seq Description Document Type Size
7 cpsc-20131231.xml EX-101.INS 1489171
8 cpsc-20131231.xsd EX-101.SCH 79227
9 cpsc-20131231_cal.xml EX-101.CAL 71040
10 cpsc-20131231_def.xml EX-101.DEF 283559
11 cpsc-20131231_lab.xml EX-101.LAB 652108
12 cpsc-20131231_pre.xml EX-101.PRE 470988
Mailing Address 278 DP ROAD SUITE D LOS ALAMOS NM 87544
Business Address 278 DP ROAD SUITE D LOS ALAMOS NM 87544 505-661-2420
Caldera Pharmaceuticals Inc (Filer) CIK: 0001518520 (see all company filings)

EIN.: 200982060 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54748 | Film No.: 14881881
SIC: 8731 Services-Commercial Physical & Biological Research